Results: 1-11 |
Results: 11

Authors: Scotton, PG Pea, F Giobbia, M Baraldo, M Vaglia, A Furlanut, M
Citation: Pg. Scotton et al., Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis, CLIN INF D, 33(9), 2001, pp. E109-E111

Authors: Baraldo, M Pea, F Poz, D Furlanut, M
Citation: M. Baraldo et al., Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients, PHARMAC RES, 43(6), 2001, pp. 547-551

Authors: Pea, F Poz, D Baraldo, M Furlanut, M
Citation: F. Pea et al., Optimisation of vancomycin regimen in neutropenic haematological patients with normal renal function - Multiple daily doses may be preferable, CLIN DRUG I, 19(3), 2000, pp. 213-218

Authors: Pea, F Porreca, L Baraldo, M Furlanut, M
Citation: F. Pea et al., High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures, J ANTIMICRO, 45(3), 2000, pp. 329-335

Authors: Pea, F Russo, D Michieli, M Baraldo, M Ermacora, A Damiani, D Baccarani, M Furlanut, M
Citation: F. Pea et al., Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia, CANC CHEMOT, 46(4), 2000, pp. 279-286

Authors: Pea, F Milaneschi, R Baraldo, M Lugatti, E Talmassons, G Furlanut, M
Citation: F. Pea et al., Ciprofloxacin disposition in elderly patients with LRTI being treated withsequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): Comparative pharmacokinetics and the role of therapeuticdrug monitoring, THER DRUG M, 22(4), 2000, pp. 386-391

Authors: Pea, F Furlanut, M Poz, D Baraldo, M
Citation: F. Pea et al., Pharmacokinetic profile of two different administration schemes of teicoplanin - Single 400mg intravenous dose vs double-refracted 200mg intramuscular doses in healthy volunteers, CLIN DRUG I, 18(1), 1999, pp. 47-55

Authors: Pea, F Milaneschi, R Baraldo, M Talmassons, G Furlanut, M
Citation: F. Pea et al., Isoniazid and its hydrazine metabolite in patients with tuberculosis, CLIN DRUG I, 17(2), 1999, pp. 145-154

Authors: Baraldo, M Ferraccioli, G Pea, F Gremese, E Furlanut, M
Citation: M. Baraldo et al., Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy, PHARMAC RES, 40(6), 1999, pp. 483-486

Authors: Wu, G Baraldo, M Furlanut, M
Citation: G. Wu et al., Inter-patient and intra-patient variations in the baseline tapping test inpatients with Parkinson's disease, ACT NEUR BE, 99(3), 1999, pp. 182-184

Authors: Pea, F Damiani, D Michieli, M Ermacora, A Baraldo, M Russo, D Fanin, R Baccarani, M Furlanut, M
Citation: F. Pea et al., Multidrug resistance modulation in vivo: The effect of cyclosporin A aloneor with dexverapamil on idarubicin pharmacokinetics in acute leukemia, EUR J CL PH, 55(5), 1999, pp. 361-368
Risultati: 1-11 |